Pre-order Enquiry
Request Free Sample
Healthcare
Aerospace & Defence
Agriculture
Automations
Chemicals & Advanced Materials
Food & Beverages
Information & Communication Technology
Oil & Gas
Power & Energy
This report contains market size and forecasts of Radiopharmaceuticals in Nuclear Medicine in China, including the following market information:
China Radiopharmaceuticals in Nuclear Medicine Market Revenue, 2016-2021, 2022-2027, ($ millions)
China Radiopharmaceuticals in Nuclear Medicine Market Sales, 2016-2021, 2022-2027, (K MT)
China top five Radiopharmaceuticals in Nuclear Medicine companies in 2020 (%)
The global Radiopharmaceuticals in Nuclear Medicine market size is expected to growth from US$ 4804.6 million in 2020 to US$ 6988.2 million by 2027; it is expected to grow at a CAGR of 5.0% during 2021-2027.
The China Radiopharmaceuticals in Nuclear Medicine market was valued at US$ XX million in 2020 and is projected to reach US$ XX million by 2027, at a CAGR of XX% during the forecast period.
QYResearch has surveyed the Radiopharmaceuticals in Nuclear Medicine manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
China Radiopharmaceuticals in Nuclear Medicine Market,
China Radiopharmaceuticals in Nuclear Medicine Market Segment Percentages,
Diagnostic Radiopharmaceuticals
Therapy Radiopharmaceuticals
Enriched Stable Isotopes
China Radiopharmaceuticals in Nuclear Medicine Market,
China Radiopharmaceuticals in Nuclear Medicine Market Segment Percentages,
Diagnostic Application
Therapeutic Application
Research
Pharmaceutical
Other
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Radiopharmaceuticals in Nuclear Medicine revenues in China market, 2016-2021 (Estimated), ($ millions)
Key companies Radiopharmaceuticals in Nuclear Medicine revenues share in China market, 2020 (%)
Key companies Radiopharmaceuticals in Nuclear Medicine sales in China market, 2016-2021 (Estimated), (K MT)
Key companies Radiopharmaceuticals in Nuclear Medicine sales share in China market, 2020 (%)
Further, the report presents profiles of competitors in the market, key players include:
Bracco Imaging S.P.A.
Cambridge Isotope Laboratories, Inc.
Cardinal Health, Inc.
Covidien, Plc
Eczacibasi-Monrol
Fujifilm Holdings Corporation
GE Healthcare (Subsidiary Of General Electric Company)
IBA Group
Isotec, Inc. (Sigma-Aldrich)
Lantheus Medical Imaging, Inc.
Nordion, Inc.
Ntp Radioisotopes (Pty), Ltd.
Siemens Healthcare (Subsidiary Of Siemens AG)
Taiyo Nippon Sanso Corporation
Urenco Limited
Rotem Industries, Ltd., Inc.
Australian Nuclear Association And Technology Organization (ANSTO)
Board of Radiation And Isotope Technology (BRIT)
Institute of Atomic Energy Polatom Radioisotope Centre
Institute of Isotopes Co., Ltd.
Institute Of Radioelement (IRE)
China Radiopharmaceuticals in Nuclear Medicine Market Revenue, 2016-2021, 2022-2027, ($ millions)
China Radiopharmaceuticals in Nuclear Medicine Market Sales, 2016-2021, 2022-2027, (K MT)
China top five Radiopharmaceuticals in Nuclear Medicine companies in 2020 (%)
The global Radiopharmaceuticals in Nuclear Medicine market size is expected to growth from US$ 4804.6 million in 2020 to US$ 6988.2 million by 2027; it is expected to grow at a CAGR of 5.0% during 2021-2027.
The China Radiopharmaceuticals in Nuclear Medicine market was valued at US$ XX million in 2020 and is projected to reach US$ XX million by 2027, at a CAGR of XX% during the forecast period.
QYResearch has surveyed the Radiopharmaceuticals in Nuclear Medicine manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
China Radiopharmaceuticals in Nuclear Medicine Market,
By Type
, 2016-2021, 2022-2027 ($ Millions) & (K MT)China Radiopharmaceuticals in Nuclear Medicine Market Segment Percentages,
By Type
, 2020 (%)Diagnostic Radiopharmaceuticals
Therapy Radiopharmaceuticals
Enriched Stable Isotopes
China Radiopharmaceuticals in Nuclear Medicine Market,
By Application
, 2016-2021, 2022-2027 ($ Millions) & (K MT)China Radiopharmaceuticals in Nuclear Medicine Market Segment Percentages,
By Application
, 2020 (%)Diagnostic Application
Therapeutic Application
Research
Pharmaceutical
Other
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Radiopharmaceuticals in Nuclear Medicine revenues in China market, 2016-2021 (Estimated), ($ millions)
Key companies Radiopharmaceuticals in Nuclear Medicine revenues share in China market, 2020 (%)
Key companies Radiopharmaceuticals in Nuclear Medicine sales in China market, 2016-2021 (Estimated), (K MT)
Key companies Radiopharmaceuticals in Nuclear Medicine sales share in China market, 2020 (%)
Further, the report presents profiles of competitors in the market, key players include:
Bracco Imaging S.P.A.
Cambridge Isotope Laboratories, Inc.
Cardinal Health, Inc.
Covidien, Plc
Eczacibasi-Monrol
Fujifilm Holdings Corporation
GE Healthcare (Subsidiary Of General Electric Company)
IBA Group
Isotec, Inc. (Sigma-Aldrich)
Lantheus Medical Imaging, Inc.
Nordion, Inc.
Ntp Radioisotopes (Pty), Ltd.
Siemens Healthcare (Subsidiary Of Siemens AG)
Taiyo Nippon Sanso Corporation
Urenco Limited
Rotem Industries, Ltd., Inc.
Australian Nuclear Association And Technology Organization (ANSTO)
Board of Radiation And Isotope Technology (BRIT)
Institute of Atomic Energy Polatom Radioisotope Centre
Institute of Isotopes Co., Ltd.
Institute Of Radioelement (IRE)
Frequently Asked Questions
This market study covers the global and regional market with an in-depth analysis of the overall growth prospects in the market. Furthermore, it sheds light on the comprehensive competitive landscape of the global market. The report further offers a dashboard overview of leading companies encompassing their successful marketing strategies, market contribution, recent developments in both historic and present contexts.
- By product type
- By End User/Applications
- By Technology
- By Region
The report provides a detailed evaluation of the market by highlighting information on different aspects which include drivers, restraints, opportunities, and threats. This information can help stakeholders to make appropriate decisions before investing.
